Physician profile

Kelsey Gray

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Torrance, CA

NPI 1912348293

$73,968.64

in general payments reported to CMS, 2019-2025

30 companies · $37K in 2025

The $37K reported for 2025 was more than what 96% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).

See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$40,500.00
Education$16,756.93
Food and Beverage$7,732.13
Travel and Lodging$4,875.83
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$1,700.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Paragonix Technologies, INC. $40,500.00 2023-2025 Sherpacool Box, Cts Canister Box, Paragonix Sherpapak Cardiac Transport System
Intuitive Surgical, INC. $23,531.33 2023-2025 Davinci Xi, Da Vinci Surgical System
Medtronic, INC. $3,193.51 2021-2025 Avalus, Octopus, Penditure
Edwards Lifesciences Corporation $2,461.07 2023-2025
Medtronic Vascular, INC. $664.30 2019-2020
Abiomed $463.10 2022-2025 Impella
Saphena Medical, INC. $382.92 2023 Venapax
Atricure, INC. $361.29 2021-2025 Atriclip Laa Exclusion System
Bolton Medical INC $331.02 2024 Treo Abdominal Stent-Graft System
Abbott Laboratories $315.00 2022-2023 Epic
Baxter Healthcare $289.88 2019-2025 Floseal, Coseal
Corcym INC $214.56 2024 Mi Detach - Aortic Cross Clamp - Delivery System Kit
Ethicon US, LLC $149.80 2024 Surgicel Nu-Knit
Zimmer Biomet Holdings, INC. $145.67 2024 Sternalock Blu System
Davol INC. $144.44 2020
Show all 30 companies
CompanyGeneral paymentsYearsTop products
La Jolla Pharmaceutical Company $120.00 2022
Hemosonics LLC $108.00 2023 Quantra Qplus System
W. L. Gore & Associates, INC. $106.28 2023 Gore Tag Conformable Thoracic Endoprosthesis
Enablecv INC. $99.46 2025
Clearflow INC. $98.15 2025 Pleuraflow System With Flowglide
Stryker Corporation $70.85 2024-2025 Na
Teleflex LLC $59.37 2024-2025 Manta
Solventum Corporation $24.46 2024 Prevena
Boston Scientific Corporation $23.64 2024 Wavewriter Alpha Prime 16
Artivion, INC. $22.90 2025 Amds-Ascyrus Medical
Lemaitre Vascular, INC. $20.90 2024 Restoreflow
Getinge USA Sales, LLC $18.79 2023 Cardiosave Hybrid, Type B Plug
Kls-Martin L.P. $16.84 2024
Livanova USA, INC. $16.46 2022
Lsi Solutions INC $14.65 2023 Cor Knot

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Kelsey Gray

$73,968.64

in general payments reported 2019-2025

Years
2019-2025
Top company
Paragonix Technologies, INC.
Context
The $37K reported for 2025 was more than what 96% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).

https://glasscript.com/doctor/1382128/kelsey-gray

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Download CSV

The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.